Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09CKF
|
|||
| Former ID |
DNC000877
|
|||
| Drug Name |
Licostinel
|
|||
| Synonyms |
Licostinel; 153504-81-5; ACEA 1021; ACEA-1021; UNII-3Z3037LJTC; 6,7-Dichloro-5-nitro-2,3-quinoxalinedione; 5-Nitro-6,7-dichloro-2,3-quinoxalinedione; 5-Nitro-6,7-dichloro-1,4-dihydro-2,3-quinoxalinedione; 6,7-Dichloro-1,4-dihydro-5-nitro-2,3-quinoxalinedione; CHEMBL289832; 3Z3037LJTC; 6,7-dichloro-5-nitro-1,4-dihydroquinoxaline-2,3-dione; 6,7-DICHLORO-5-NITROQUINOXALINE-2,3(1H,4H)-DIONE; 2,3-Quinoxalinedione, 6,7-dichloro-1,4-dihydro-5-nitro-; Licostinel [USAN]; Licostinel [USAN:INN]; C8H3Cl2N3O4; AC1NUOFE; Licostinel (USAN/
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Neurological disorder [ICD-11: 6B60] | Discontinued in Phase 1 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H3Cl2N3O4
|
|||
| Canonical SMILES |
C1=C2C(=C(C(=C1Cl)Cl)[N+](=O)[O-])NC(=O)C(=O)N2
|
|||
| InChI |
1S/C8H3Cl2N3O4/c9-2-1-3-5(6(4(2)10)13(16)17)12-8(15)7(14)11-3/h1H,(H,11,14)(H,12,15)
|
|||
| InChIKey |
CHFSOFHQIZKQCR-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 153504-81-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003616) | |||
| REF 2 | Neuroprotective agents for the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep. 2003 Jan;3(1):9-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.